Shots:
2023 remained a year of notable approvals by the US FDA. Around 55 drugs were approved, by the US FDA in 2023
PharmaShots, in an enlightening report, brings a summarized analysis of the approved drugs. The most explored section remains Oncology, Neurology, and Hematology
For the complete report with analysis, reach out to us…
Conference Series is delighted to welcome you to attend the “35th World Congress for Neurorehabilitation” to be held in Amsterdam, Netherlands, from August 07-08, 2023. The exhilarating scientific program will focus on Clinical Neurology, Cognitive Neuroscience Neurorehabilitation, Neurosurgery, Psychiatry.
The two days program will be filled with insightful presentations, engaging discussions, and networking opportunities. This…
Shots:
Jay spoke about the role of AI-based EEG neurobiomarkers in the development of therapies to treat neurologic diseases
Jay also talked about the use of the EEG analytics platform for dose determination clinical research
The interview gives an understanding of Beacon Biosignals' vision to accelerate new treatment options for neurological and psychiatric diseases
Smriti: Throw…
Shots:
The interview provided an understanding of the data from its Alzheimer’s disease pipeline at the AD/PD Conference
The spokespeople also talked about the clinical trial data and key mechanisms of Eisai’s anti-amyloid compound in AD
The discussion showed gave a gist of four key symposium presentations that showed how its lead candidate has the…

